跳至主要内容
临床试验/NCT04187820
NCT04187820招募中不适用

Effect of Acupuncture on Crohn's Disease Via the Regulation of Trp-kyn Metabolism in Brain-gut Axis

Shanghai Institute of Acupuncture, Moxibustion and Meridian2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2019年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
60
试验地点
2
主要终点
Clinical remission

研究概览

简要总结

To observe the clinical effect of acupuncture on Crohn's disease (CD) and its influence on brain function activity and the TRY-KYN metabolism level, and to screen the brain image markers of acupuncture on CD

详细描述

  1. Effect of acupuncture on symptoms of CD
  2. Effect of acupuncture on brain functional activity of CD
  3. Effect of acupuncture on intestinal and plasma TRP-KYN metabolism level of CD
  4. Screen the brain image markers of acupuncture in the treatment of CD

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
16 Years 至 70 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • aged 16-70;
  • patients with mild or moderate active disease (150 ≤ CDAI < 450);
  • patients who are not responsive, intolerant, dependent or refused to use at least mesalazine, glucocorticoid, immunomodulator (azathioprine, methotrexate), anti TNF alpha preparation;
  • patients were not taking medication or were only taking one or more of the following drugs: [prednisone ≤15mg/d, azathioprine (≤1mg/kg/d), methotrexate (≤15mg/w) or mesalazine (≤4g/d)] and prednisone was used for at least 1 month, while azathioprine, methotrexate or mesalazine was used for at least 3 months;
  • those who did not use anti-TNF alpha and other agents within 3 months before entering the study;
  • those who have never experienced acupuncture;
  • patients signing informed consent.

排除标准

  • patients who are recently pregnant or in pregnancy or lactation;
  • patients with serious organic diseases;
  • patients diagnosed as psychosis;
  • patients who take antibiotics, probiotics, traditional Chinese medicine and other drugs at the same time, or who suffer from multiple diseases and need to take other drugs for a long time, and may affect the observation of the efficacy of this trial;
  • severe skin diseases (such as erythema nodosum, pyoderma gangrenosum, etc.), eye diseases (such as iritis, uveitis, etc.), thromboembolic diseases and other serious extraintestinal manifestations;
  • there are serious intestinal fistula, abdominal abscess, intestinal stenosis and obstruction, perianal abscess, gastrointestinal hemorrhage, intestinal perforation and other complications;
  • patients with short bowel syndrome who have undergone abdominal or gastrointestinal surgery in the past half a year;
  • there are skin diseases or defects in the selected area of acupuncture and moxibustion that cannot be performed.

结局指标

主要结局

Clinical remission

时间窗: Week 12

Crohn's disease activity index (CDAI)less than 150 and decreased more than 70

次要结局

  • Clinical remission(Week 24, 36 and 48)
  • Clinical response(Week 12, 24, 36 and 48)
  • Crohn's disease activity index (CDAI)score(Week 12, 24, 36 and 48)
  • Crohn's disease endoscopic index of severity (CDEIS)(Week 48)
  • Brain functional and structural changes(Week 12)
  • Inflammatory bowel disease questionnaire (IBDQ)(Week 12 and 24)
  • Hospital anxiety and depression scale (HADS)(Week 12 and 24)
  • The proportion of recurrences(Week 48)
  • laboratory test(Week 12, 24, 36 and 48)
  • Plasma and intestinal TRP-KYN metabolism level(Week 12)

研究者

发起方
Shanghai Institute of Acupuncture, Moxibustion and Meridian
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Effect of Acupuncture on Mild to Moderate Active... | 临床试验